Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Clinical trial NCT00257192 · TERMINATED
Trial details
- NCT number
- NCT00257192
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.